Cargando…
A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy
Autores principales: | Chang, Mei H., Cowman, Kelsie, Guo, Yi, Bao, Hongkai, Bernstein, Peter S., Gendlina, Inessa, Nori, Priya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780055/ https://www.ncbi.nlm.nih.gov/pubmed/35074337 http://dx.doi.org/10.1016/j.ajog.2022.01.018 |
Ejemplares similares
-
522. Evaluation of Three COVID-19 Monoclonal Antibody Regimens in the Context of Rising B.1.526 Prevalence in New York City
por: Bao, Hongkai, et al.
Publicado: (2021) -
Assessment of unvaccinated and vaccinated patients with coronavirus disease 2019 (COVID-19) treated with monoclonal antibodies during the delta wave (July 1–August 20, 2021): a retrospective observational monocentric study
por: Guo, Yi, et al.
Publicado: (2022) -
114. Optimization of Inpatient Antibiotic Use via an Electronic Antimicrobial Stewardship Module and an Infectious Diseases Pharmacy Resident
por: Chen, Victor, et al.
Publicado: (2021) -
Elucidating the role of procalcitonin as a biomarker in hospitalized COVID-19 patients
por: Cowman, Kelsie, et al.
Publicado: (2022) -
Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in respiratory cultures and diagnostic performance of the MRSA nasal polymerase chain reaction (PCR) in patients hospitalized with coronavirus disease 2019 (COVID-19) pneumonia
por: Punjabi, Chitra D., et al.
Publicado: (2020)